GeoVax Labs, Inc.
GOVX, GOVXWOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5M | $4.0M | $0 | $81,526 | $385,501 | $1.8M |
| Operating income | −$21.6M | −$25.1M | −$26.7M | −$14.0M | −$18.7M | −$2.8M |
| Net income | −$21.5M | −$25.0M | −$26.0M | −$14.0M | −$18.6M | −$3.0M |
| Total assets | $6.3M | $8.2M | $9.3M | $31.3M | $11.8M | $10.4M |
| Total liabilities | $2.5M | $3.1M | — | $4.7M | $7.4M | $825,047 |
| Equity | $3.8M | $5.0M | $5.8M | $26.6M | $4.4M | $9.6M |
| EPS (diluted) | $-22.40 | $-120.46 | $-14.29 | $-12.39 | $-3.04 | — |
| Shares out. | 13.8M | 2.2M | 26.3M | 7.1M | 6.3M | 13.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −869.3%
- Net margin
- −862.3%
- Return on equity
- −561.2%
- Return on assets
- −338.5%
- Return on capital (ROCE)
- −491.2%
- Liabilities / assets
- 39.7%
- Debt / equity
- 0.66×
- Book value / share
- $0.28
- Revenue growth (YoY)
- −37.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -95.37distress
- Accruals / assets
- 0.1%clean
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2026
- Intracoastal Capital, LlcPassive (13G)May 13, 2026
- L1 Capital Global Opportunities Master Fund, Ltd.Passive (13G)Feb 17, 2026
- Ayrton Capital LlcPassive (13G)Feb 11, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Spencer John N JrDirector | Oct 17, 2025 | Buy | 10,000 | $0.55 |
| Mckee Kelly T. Jr.Officer — Chief Medical Officer | Aug 7, 2025 | Buy | 1,107 | $0.67 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity sale · Regulation FD disclosureMay 19, 2026
- Results of operationsMay 14, 2026
- Entered a material agreement · Unregistered equity saleMay 7, 2026
- Results of operationsApr 15, 2026
- Entered a material agreement · Unregistered equity saleMar 31, 2026
- Entered a material agreement · Unregistered equity sale · Regulation FD disclosureFeb 17, 2026
- Modified shareholder rights · Amended charter or bylawsJan 12, 2026
- Entered a material agreement · Regulation FD disclosureDec 22, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- S-1FORM S-1May 26, 2026
- 8-KFORM 8-KMay 19, 2026
- DEFR14AFORM DEFR14AMay 18, 2026
- SCHEDULE 13G/AMay 15, 2026
- 8-KFORM 8-KMay 14, 2026
- 10-QFORM 10-QMay 14, 2026
- SCHEDULE 13G/AMay 13, 2026
- PRER14AMay 8, 2026
- 8-KFORM 8-KMay 7, 2026
- DEF 14AFORM DEF 14AApr 27, 2026
- EFFECTApr 21, 2026
- EFFECTApr 21, 2026
- EFFECTApr 17, 2026
- EFFECTApr 17, 2026
- EFFECTApr 17, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.